Multiply Labs’ cover photo
Multiply Labs

Multiply Labs

Robotics Engineering

San Francisco, California 6,368 followers

Developing advanced robotics technology to manufacture next-gen therapies at industrial scale.

About us

Multiply Labs develops advanced robotic systems that manufacture next-gen therapies at scale. We believe that automation is the key to enable life-saving therapies to reach all the patients who need them. We work with the global leaders in the pharmaceutical and biotech space (see our posts to keep up with the latest commercial announcements). And don't forget to check out our peer-reviewed studies with UCSF and Stanford to review our robots' performance in detail!

Website
http://multiplylabs.com
Industry
Robotics Engineering
Company size
11-50 employees
Headquarters
San Francisco, California
Type
Privately Held
Specialties
robotics and biomanufacturing

Locations

Employees at Multiply Labs

Updates

  • View organization page for Multiply Labs

    6,368 followers

    We’re thrilled to announce our collaboration with Legend Biotech, focused on automating cell therapy manufacturing! Excited to work with some of the best scientists in the field.  Through this collaboration, Legend Biotech will evaluate our robotic technologies, and secure priority access to those automated systems. The Multiply Labs approach to automating cell therapy manufacturing - as seen in this video - is rooted in the promising results of our  peer-reviewed study in Cytotherapy, which highlighted statistical equivalence between manual and automated cell expansion processes. This collaboration will help showcase the potential of our flexible automation solutions, bringing us closer to our vision of reducing labor costs and increasing manufacturing throughput. Learn more about the news here: https://bit.ly/3TG8JsG   #CellTherapy #Robotics #Innovation #Pharma #BioTech

  • Multiply Labs reposted this

    View profile for Fred (Federico) Parietti

    Co-Founder and CEO at Multiply Labs

    I am excited to share this latest article covering our story from Forbes! From our earliest prototypes to today’s robotic clusters, our 𝗺𝗶𝘀𝘀𝗶𝗼𝗻 has remained the same: to build the 𝘄𝗼𝗿𝗹𝗱’𝘀 𝗯𝗲𝘀𝘁 𝗿𝗼𝗯𝗼𝘁𝘀 and use them to make the 𝗺𝗼𝘀𝘁 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘄𝗶𝗱𝗲𝗹𝘆 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲. Read the article here: https://lnkd.in/gMRy8R3u I am super proud of our team - their 𝙗𝙧𝙞𝙡𝙡𝙞𝙖𝙣𝙘𝙚, 𝙧𝙚𝙨𝙞𝙡𝙞𝙚𝙣𝙘𝙚, 𝙖𝙣𝙙 𝙘𝙤𝙢𝙢𝙞𝙩𝙢𝙚𝙣𝙩 have carried us from our early pilots into deployments with some of the world leaders in both robotics and pharma. This Forbes article, highlighting our collaboration with Universal Robots, is a reminder of 𝗵𝗼𝘄 𝗳𝗮𝗿 𝘄𝗲 𝗵𝗮𝘃𝗲 𝗰𝗼𝗺𝗲 and how much work lies ahead. The future of biomanufacturing will be written by those who can scale therapies to every patient who needs them. 𝗢𝗻𝘄𝗮𝗿𝗱𝘀, 𝗮𝗻𝗱 𝗯𝗿𝗮𝘃𝗼 𝘁𝗼 𝘁𝗵𝗲 𝘁𝗲𝗮𝗺!

    • No alternative text description for this image
    • No alternative text description for this image
  • 𝗧𝗿𝗮𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹𝗹𝘆 𝗺𝗮𝗻𝘂𝗮𝗹 𝗮𝗻𝗱 '𝗮𝗿𝘁𝗶𝘀𝗶𝗻𝗮𝗹' 𝗰𝗲𝗹𝗹 𝗮𝗻𝗱 𝗴𝗲𝗻𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗰𝗮𝗻 𝗰𝗼𝘀𝘁 𝗮𝗻𝘆𝘄𝗵𝗲𝗿𝗲 𝗳𝗿𝗼𝗺 $𝟯𝟬𝟬𝗞-$𝟮𝗠 𝗽𝗲𝗿 𝗱𝗼𝘀𝗲. We are partnering with Universal Robots to make cell and gene therapy manufacturing faster, cheaper, and more reliable than ever by harnessing the power of collaborative robots. Learn more here: https://lnkd.in/eZAEr45Z #biotech #robotics #celltherapy #genetherapy #automation #biomanufacturing #universalrobots #cobot #urmultiplylabs

  • At Multiply Labs, we believe in 𝗯𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝘁𝗿𝘂𝘀𝘁 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗱𝗮𝘁𝗮. Peer-reviewed studies and pre-publications with University of California, San Francisco and Stanford GMP Facility: Laboratory for Cell and Gene Medicine show how Multiply Labs’ robotic automation 𝗽𝗿𝗼𝘃𝗲𝘀 𝘀𝘁𝗮𝘁𝗶𝘀𝘁𝗶𝗰𝗮𝗹 𝗲𝗾𝘂𝗶𝘃𝗮𝗹𝗲𝗻𝗰𝗲 with traditional manual processes. This enables robots to truly make cell therapies accessible at scale, achieving 𝟳𝟰% 𝗹𝗼𝘄𝗲𝗿 𝗰𝗼𝘀𝘁𝘀 and 𝟭𝟬𝟬𝘅 𝗺𝗼𝗿𝗲 𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝗽𝘂𝘁 per square foot of cleanroom. To learn more: Learn more here: https://lnkd.in/eZAEr45Z #cobot #biotech #robotics #automation #urmultiplylabs

  • Multiply Labs reposted this

    View profile for Fred (Federico) Parietti

    Co-Founder and CEO at Multiply Labs

    𝗢𝘂𝗿 𝗻𝗲𝘄𝗲𝘀𝘁 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝘆 𝗟𝗮𝗯𝘀 𝗘𝘅𝗽𝗹𝗮𝗶𝗻𝗲𝗿 𝗩𝗶𝗱𝗲𝗼 𝗵𝗮𝘀 𝗱𝗿𝗼𝗽𝗽𝗲𝗱! With our newly announced Universal Robots partnership comes our 𝗹𝗮𝘁𝗲𝘀𝘁 𝗲𝘅𝗽𝗹𝗮𝗶𝗻𝗲𝗿, where we cover everything from the incredible 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗼𝗳 𝗰𝗲𝗹𝗹 𝗮𝗻𝗱 𝗴𝗲𝗻𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 to how we can use 𝗿𝗼𝗯𝗼𝘁𝗶𝗰𝘀 to 𝙧𝙖𝙙𝙞𝙘𝙖𝙡𝙡𝙮 𝙞𝙣𝙘𝙧𝙚𝙖𝙨𝙚 𝙥𝙖𝙩𝙞𝙚𝙣𝙩 𝙖𝙘𝙘𝙚𝙨𝙨 to these advanced treatments. True story: when we first looked at how cell and gene therapies were made, we were shocked. Highly trained operators spend hours pipetting, shaking, and culturing cells, all by hand. We knew robots were the only answer. And the results were astonishing: → 𝟳𝟰% 𝗹𝗼𝘄𝗲𝗿 manufacturing 𝗰𝗼𝘀𝘁𝘀 → 𝟭𝟬𝟬𝘅 𝗺𝗼𝗿𝗲 𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝗽𝘂𝘁 per square foot of cleanroom → Dramatically improved 𝗰𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝗰𝘆 and 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 Because our robots use the same instruments, consumables, and workflows scientists already use, pharmaceutical companies can scale without reinventing their regulatory pathway, which can be extremely expensive and slow. The future of cell and gene therapy manufacturing is robotic - smarter, cleaner, and more accessible than ever before! Learn more here: https://lnkd.in/ggJgx_eN #biotech #robotics #celltherapy #genetherapy #automation #biomanufacturing #universalrobots #cobot #urmultiplylabs

  • Multiply Labs reposted this

    🚀 Pioneering Automation in Cell & Gene Therapy In record time, Fedegari Americas and Multiply Labs have joined forces to deliver the first automated solutions for Cell & Gene Therapy manufacturing—bringing robotics, flexibility, and innovation to one of the fastest-growing areas in life sciences. Our new system is: ✅ Compact – fitting into existing facilities with ease ✅ Modular & Scalable – growing with your production needs ✅ Flexible – adapting to diverse processes ✅ Fully Automated – leveraging robotics for precision and efficiency By combining Fedegari’s expertise in sterile process equipment with Multiply Labs’ robotics innovation, we are helping customers accelerate development timelines, ensure consistent quality, and meet the highest safety standards in advanced therapies. This is more than a product launch—it’s a new chapter in how Cell & Gene Therapy is made. Together, we’re setting the standard for speed, scalability, and reliability in a field that changes lives. #CellAndGeneTherapy #Automation #Robotics #LifeSciences #Innovation #Fedegari #MultiplyLabs #AdvancedTherapies #Biotech #Pharma

  • We are thrilled to 𝙤𝙛𝙛𝙞𝙘𝙞𝙖𝙡𝙡𝙮 𝙖𝙣𝙣𝙤𝙪𝙣𝙘𝙚 our 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽 with Universal Robots! Multiply Labs is now the 𝗳𝗶𝗿𝘀𝘁 𝗼𝗳𝗳𝗶𝗰𝗶𝗮𝗹 Universal Robots (𝗨𝗥) 𝗽𝗮𝗿𝘁𝗻𝗲𝗿 𝗶𝗻 𝘁𝗵𝗲 𝗰𝗲𝗹𝗹 𝗮𝗻𝗱 𝗴𝗲𝗻𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝘀𝗲𝗰𝘁𝗼𝗿. By combining our robotic manufacturing platforms with UR’s industry-leading cobots, we’re transforming the production of personalized, life-saving cell and gene therapies. The results speak for themselves: 💲Over 𝟳𝟬% 𝗿𝗲𝗱𝘂𝗰𝘁𝗶𝗼𝗻 in manufacturing costs for biotech companies 🦾 Greater 𝘀𝗰𝗮𝗹𝗮𝗯𝗶𝗹𝗶𝘁𝘆 without compromising 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 📦 𝗙𝗮𝘀𝘁𝗲𝗿 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 of 𝙖𝙙𝙫𝙖𝙣𝙘𝙚𝙙 𝙩𝙝𝙚𝙧𝙖𝙥𝙞𝙚𝙨 to patients who need them most This collaboration sets a new standard for 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆, 𝗰𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝗰𝘆, 𝗮𝗻𝗱 𝗮𝗰𝗰𝗲𝘀𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆 in biomanufacturing, harnessing the power of 𝙘𝙤𝙡𝙡𝙖𝙗𝙤𝙧𝙖𝙩𝙞𝙫𝙚 𝙧𝙤𝙗𝙤𝙩𝙨 to bring advanced automation to the 𝗰𝗲𝗹𝗹 𝗮𝗻𝗱 𝗴𝗲𝗻𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝘀𝗲𝗰𝘁𝗼𝗿. To read more about our collaboration, check out our joint press release here: https://lnkd.in/eBPBNQ-G #biotech #automation #robotics #celltherapy #genetherapy #partnership #cobot #biomanufacturing #universalrobots #urmultiplylabs

    • No alternative text description for this image
  • Multiply Labs reposted this

    74% cost reduction and up to 100x more doses… Multiply Labs uses robots to automate cell therapy production. The robots mimic human processes and scale output, making life-saving therapies far more accessible 👏 This approach has been proven effective in peer-reviewed studies with UCSF and Stanford. Learn how Multiply Labs did it: http://urrobots.com/iUi

  • Our 2025 interns are using VR headsets to teleoperate humanoid robots for pharmaceutical manufacturing, where sterility is critical. In cell therapy, a single contamination can mean losing a treatment intended to save a patient’s life. Robots offer the precision and consistency to help prevent that. This is what our culture is built on: empowering ambitious people to operate at the edge of possibility, knowing they’ll rise to the challenge. It’s how we accelerate talent - and how we create the robotic future of biomanufacturing. If this type of work excites you, follow us to learn about upcoming opportunities to join the team and work on projects at the frontier of robotics and biomanufacturing. Thank you to NVIDIA Healthcare and NVIDIA Robotics for your support in making this happen! #Robotics #Biomanufacturing #VR #Pharma #Innovation #internship

    View profile for Fred (Federico) Parietti

    Co-Founder and CEO at Multiply Labs

    The year is 2025 - and our 𝗶𝗻𝘁𝗲𝗿𝗻𝘀 are using 𝗩𝗥 𝗵𝗲𝗮𝗱𝘀𝗲𝘁𝘀 to 𝙩𝙚𝙡𝙚𝙤𝙥𝙚𝙧𝙖𝙩𝙚 𝙝𝙪𝙢𝙖𝙣𝙤𝙞𝙙 𝙧𝙤𝙗𝙤𝙩𝙨. Why does this matter?  𝗧𝗛𝗘 𝗜𝗠𝗣𝗔𝗖𝗧: In cell therapy manufacturing, a 𝘀𝗶𝗻𝗴𝗹𝗲 𝗶𝗻𝘀𝘁𝗮𝗻𝗰𝗲 𝗼𝗳 𝗰𝗼𝗻𝘁𝗮𝗺𝗶𝗻𝗮𝘁𝗶𝗼𝗻 can 𝙙𝙚𝙨𝙩𝙧𝙤𝙮 𝙖 𝙩𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩 that can drastically help patients in need. Our purpose-built robotic systems already automate the “main” process, but people (one of the main causes of contamination) still have to load them! We believe that 𝙖𝙪𝙩𝙤𝙣𝙤𝙢𝙤𝙪𝙨 𝙡𝙤𝙖𝙙𝙞𝙣𝙜 by humanoid robots solves this problem and ensures sterility.  𝗧𝗛𝗘 𝗪𝗛𝗢: I believe that 𝘁𝗮𝗹𝗲𝗻𝘁 𝗶𝘀 𝗲𝘃𝗲𝗿𝘆𝘄𝗵𝗲𝗿𝗲 - and when you give ambitious young people the space and trust to take on challenges at the edge of possibility, they do 𝚎̲𝚡̲𝚝̲𝚛̲𝚊̲𝚘̲𝚛̲𝚍̲𝚒̲𝚗̲𝚊̲𝚛̲𝚢̲ things. Watching our engineering interns tackle problems that once required teams of PhDs is a reminder of just how quickly robotics is advancing, and how exciting it is to be 𝘣𝘶𝘪𝘭𝘥𝘪𝘯𝘨 𝘪𝘯 𝘳𝘰𝘣𝘰𝘵𝘪𝘤𝘴 right now! We are very grateful and excited for our collaboration with NVIDIA Healthcare, and for game-changing technologies like the NVIDIA Robotics’ GR00T foundation models! This ultra fast pace of development would not have been possible without their support! #robotics #biomanufacturing #VR #humanoid #celltherapy #internship #nvidia #gr00t

  • Multiply Labs reposted this

    View profile for Fred (Federico) Parietti

    Co-Founder and CEO at Multiply Labs

    I believe that the future of biomanufacturing is completely autonomous production floors, including 𝙧𝙤𝙗𝙤𝙩𝙨 𝙡𝙤𝙖𝙙𝙞𝙣𝙜 𝙤𝙩𝙝𝙚𝙧 𝙧𝙤𝙗𝙤𝙩𝙨! Humanoids aren’t the answer for every task, but their human-like design makes them intuitive to control and a great bridge between the unstructured physical world and more efficient, purpose-built robotic systems . Here’s our humanoid standing in front of one of our Multiply Labs robotic clusters for cell therapy manufacturing! 𝗡𝗲𝘅𝘁 𝗧𝘂𝗲𝘀𝗱𝗮𝘆, we’re excited to share a closer look at one of the 𝗰𝗼𝗼𝗹𝗲𝘀𝘁 𝗿𝗼𝗯𝗼𝘁𝗶𝗰𝘀 𝗽𝗿𝗼𝗷𝗲𝗰𝘁𝘀 I have ever seen - combining 𝙝𝙪𝙢𝙖𝙣𝙤𝙞𝙙𝙨, 𝙑𝙍 𝙝𝙚𝙖𝙙𝙨𝙚𝙩𝙨, 𝙖𝙣𝙙 𝙣𝙚𝙭𝙩-𝙜𝙚𝙣 𝙗𝙞𝙤𝙡𝙤𝙜𝙞𝙘𝙖𝙡 𝙩𝙝𝙚𝙧𝙖𝙥𝙞𝙚𝙨. Can you guess where this is going? Let me know!! #robotics #biomanufacturing #humanoidrobots #VR #pharma #future

    • No alternative text description for this image

Similar pages

Browse jobs

Funding